Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Matteo Ferro, Bernardo Rocco, Martina Maggi, Giuseppe Lucarelli, Ugo Giovanni Falagario, Francesco Del Giudice, Felice Crocetto, Biagio Barone, Evelina La Civita, Francesco Lasorsa, Antonio Brescia, Michele Catellani, Gian Maria Busetto, Octavian Sabin Tataru & Daniela Terracciano. (2023) Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification. Expert Review of Molecular Diagnostics 0:0, pages 1-10.
Read now
Read now
Articles from other publishers (23)
Diane Tomalty, Olivia Giovannetti, Johanna Hannan, Barry Komisaruk, Sue Goldstein, Irwin Goldstein & Michael Adams. (2022) Should We Call It a Prostate? A Review of the Female Periurethral Glandular Tissue Morphology, Histochemistry, Nomenclature, and Role in Iatrogenic Sexual Dysfunction. Sexual Medicine Reviews 10:2, pages 183-194.
Crossref
Crossref
Bakheet E.M. Elsadek & Mohammed H. Hassan. (2021) Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy. Biochemistry and Biophysics Reports 26, pages 100966.
Crossref
Crossref
Herve Aloysius & Longqin Hu. (2020) Synthesis and evaluation of new peptide-linked doxorubicin conjugates as prodrugs activated by prostate-specific antigen. Medicinal Chemistry Research 29:7, pages 1280-1299.
Crossref
Crossref
Herve Aloysius & Longqin Hu. (2020) Synthesis and evaluation of new 4-peptidamido-2-fluorobenzyl phosphoramide mustard conjugates as prodrugs activated by prostate-specific antigen. Medicinal Chemistry Research 29:7, pages 1264-1279.
Crossref
Crossref
Herve Aloysius & Longqin Hu. (2015) Improving the Specificity of the Prostate-Specific Antigen Substrate Glutaryl-Hyp-Ala-Ser-Chg-Gln as a Promoiety. Chemical Biology & Drug Design 86:4, pages 837-848.
Crossref
Crossref
Herve Aloysius & Longqin Hu. (2015) Targeted Prodrug Approaches for Hormone Refractory Prostate Cancer. Medicinal Research Reviews 35:3, pages 554-585.
Crossref
Crossref
Bakheet Elsadek, Ralph Graeser, Norbert Esser, Cynthia Schäfer-Obodozie, Khalid Abu Ajaj, Clemens Unger, André Warnecke, Tahia Saleem, Nagla El-Melegy, Hafez Madkor & Felix Kratz. (2010) Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study. European Journal of Cancer 46:18, pages 3434-3444.
Crossref
Crossref
Bakheet Elsadek, Ralph Graeser, André Warnecke, Clemens Unger, Tahia Saleem, Nagla El-Melegy, Hafez Madkor & Felix Kratz. (2010) Optimization of an Albumin-Binding Prodrug of Doxorubicin That Is Cleaved by Prostate-Specific Antigen. ACS Medicinal Chemistry Letters 1:5, pages 234-238.
Crossref
Crossref
Ralph Graeser, Da-Eun Chung, Norbert Esser, Sandra Moor, Christoph Schächtele, Clemens Unger & Felix Kratz. (2007) Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP). International Journal of Cancer 122:5, pages 1145-1154.
Crossref
Crossref
Md Imtaiyaz Hassan, Vijay Kumar, Tej P. Singh & Savita Yadav. (2007) Structural Model of Human PSA: A Target for Prostate Cancer Therapy. Chemical Biology & Drug Design 70:3, pages 261-267.
Crossref
Crossref
Christina V. Obiezu & Eleftherios P. Diamandis. (2005) Human tissue kallikrein gene family: applications in cancer. Cancer Letters 224:1, pages 1-22.
Crossref
Crossref
B. Bindukumar, Stanley A. Schwartz, Madhavan P.N. Nair, Ravikumar Aalinkeel, Elzbieta Kawinski & Kailash C. Chadha. (2005) Prostate-Specific Antigen Modulates the Expression of Genes Involved in Prostate Tumor Growth. Neoplasia 7:3, pages 241-252.
Crossref
Crossref
Deborah DeFeo-Jones, Victor M. Garsky, Bradley K. Wong, Dong-Mei Feng, Trina Bolyar, Kathleen Haskell, David M. Kiefer, Karen Leander, Elizabeth McAvoy, Patricia Lumma, Jenny Wai, Edith T. Senderak, Sherri L. Motzel, Kevin Keenan, Matthew Van Zwieten, Jiunn H. Lin, Roger Freidinger, Joel Huff, Allen Oliff & Raymond E. Jones. (2000) A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo. Nature Medicine 6:11, pages 1248-1252.
Crossref
Crossref
Chun-Yang Fan, Jianzhou Wang & E. Leon Barnes. (2000) Expression of Androgen Receptor and Prostatic Specific Markers in Salivary Duct Carcinoma. The American Journal of Surgical Pathology 24:4, pages 579-586.
Crossref
Crossref
Kenichi Tazawa, Yuka Kurihara, Shingo Kamoshida, Kazuhiro Tsukada & Yutaka Tsutsumi. (2002) Localization of prostate‐specific antigen‐like immunoreactivity in human salivary gland and salivary gland tumors. Pathology International 49:6, pages 500-505.
Crossref
Crossref
Yvonne Fulla, Catherine Vuillemard, Maya Megarbane, Luc Nonnenmacher, Bernard Debré, Sophie Conquy, Thierry Flam, Nicolas Thiounn & Marc Zerbib. (1999) Discordances entre les dosages de PSA : comparaison PSA, PSA libre, PSA complexé. Revue Française des Laboratoires 1999:312, pages 85-90.
Crossref
Crossref
Ferdinando MannelloFrancesca Luchetti, Domenico Lancioli, Serafina BattistelliStefano Papa & Giancarlo Gazzanelli. (1998) Prostate-specific Antigen Expression in Neoplastic Human Myeloid Cell Lines. Clinical Chemistry 44:9, pages 1991-1993.
Crossref
Crossref
Katherine Meyer-Siegler, Ron A. Fattor & Perry B. Hudson. (1998) Expression of Macrophage Migration Inhibitory Factor in the Human Prostate. Diagnostic Molecular Pathology 7:1, pages 44-50.
Crossref
Crossref
Ferdinando Mannello, Leone Condemi, Antonella Cardinali, Giuseppe Bianchi & Giancarlo Gazzanelli. (1998) High Concentrations of Prostate-Specific Antigen in Urine of Women Receiving Oral Contraceptives. Clinical Chemistry 44:1, pages 181-183.
Crossref
Crossref
Ferdinando Mannello, Giovanni Miragoli, Giuseppe Bianchi & Giancarlo Gazzanelli. (1997) Prostate-Specific Antigen in Ascitic Fluid. Clinical Chemistry 43:8, pages 1461-1462.
Crossref
Crossref
M. Vogl, M.M. Müller & W. Höltl. (1997) Clinical usefulness of percentage of free serum prostate specific antigen. Clinica Chimica Acta 258:1, pages 79-90.
Crossref
Crossref
Wolfgang Henke, Monika Jung, Klaus Jung, Michael Lein, Horst Schlechte, Christoph Berndt, Birgit Rudolph, Dietmar Schnorr & Stefan A. Loening. (1997) Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. International Journal of Cancer 70:1, pages 52-56.
Crossref
Crossref
I. Abbate, M.D. Musci, A. Paradiso, F. Schittulli & M. Correale. (2018) Determination of Free PSA in Breast Cancer Cytosols by IRMA. The International Journal of Biological Markers 11:1, pages 53-54.
Crossref
Crossref